SABRE hyperpolarized anticancer agents for use in 1 H MRI

Fear, Elizabeth J, Kennerley, Aneurin J orcid.org/0000-0002-7599-7461, Rayner, Peter J orcid.org/0000-0002-6577-4117 et al. (3 more authors) (2022) SABRE hyperpolarized anticancer agents for use in 1 H MRI. Magnetic Resonance in Medicine. pp. 11-27. ISSN 1522-2594

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2022 The Authors. Magnetic Resonance in Medicine published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine.
Dates:
  • Accepted: 5 January 2022
  • Published (online): 7 March 2022
  • Published: July 2022
Institution: The University of York
Academic Units: The University of York > Faculty of Sciences (York) > Hull York Medical School (York)
The University of York > Faculty of Sciences (York) > Chemistry (York)
Depositing User: Pure (York)
Date Deposited: 15 Mar 2022 09:40
Last Modified: 06 Dec 2023 14:37
Published Version: https://doi.org/10.1002/mrm.29166
Status: Published
Refereed: Yes
Identification Number: https://doi.org/10.1002/mrm.29166

Download

Filename: Magnetic_Resonance_in_Med_2022_Fear_SABRE_hyperpolarized_anticancer_agents_for_use_in_1H_MRI_1_.pdf

Description: Magnetic Resonance in Med - 2022 - Fear - SABRE hyperpolarized anticancer agents for use in 1H MRI (1)

Licence: CC-BY 2.5

Export

Statistics